WOMEN’S HEALTH

A long-standing focus supported by specialist expertise

Women’s health has historically been one of Contrad’s key areas of interest. As part of a wider healthcare group with established operations in Eastern Europe, Contrad benefits from long-standing relationships with national gynaecological societies, reproductive-medicine associations and specialist networks.

These connections support a predominantly medical-promotion model built on scientific exchange, healthcare-professional education and clinical evidence.

The Group’s portfolio includes a line of OTC antiviral medicinal products used in the management of HPV infection, as well as an inositol-based product in reproductive health and fertility.

Building on this experience, Contrad intends to expand its portfolio for women of reproductive age.

Areas of particular interest include:

• Fertility and reproductive health
• Pain associated with endometriosis and other gynaecological conditions
• Differentiated non-hormonal therapeutic options
• Products addressing clearly defined unmet needs in women’s healthcare

Contrad focuses on products with a clear mechanism or scientific rationale, meaningful differentiation and well-designed clinical studies demonstrating their activity. The evidence must support concise, credible medical communication to gynaecologists and other relevant healthcare professionals.